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Aim. To determine the difference in hospi-
tal outcomes between percutaneous coro-
nary intervention (PCI) and conservative 
treatment of elderly female patients hos-
pitalized for acute coronary syndrome 
(ACS).
Material and Methods. This controlled 
study included 123 female patients admit-
ted to the Clinic for heart and cardiovas-
cular diseases University Hospital of Split 
with a diagnosis of ACS and multiple car-
diovascular risk factors. We recorded their 
habits, history, demographics, presenting 
symptoms, electrocardiograms, ultra-
sound results, laboratory tests, diagnostic 
tests and treatment. We compared these 
data between the two groups, i.e., those 
treated with conservative therapy and 
those treated with PCI.
Results. There were fewer arrhythmias 
(P<0.001) and episodes of heart failure 
(P<0.001) during hospitalization in the 
PCI group than in the conservative ther-
apy group. There was no significant differ-
ence in complications between the groups 
(P=0.887).
Conclusion. Elderly female patients with 
ACS treated with PCI had less arrhythmias 
and heart failure during hospitalization 
than those treated with conservative ther-
apy and there was no difference in com-
plications. These results suggest that even 
high risk patients have better outcomes af-
ter treatment with PCI, and therefore PCI 
is suggested as first-line treatment in these 
patients, regardless of risk factors.
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INTRODUCTION
Cardiovascular diseases and especially 
acute coronary syndrome (ACS) are the 
leading cause of death in industrialized 
countries with an incidence of 3 per 1000 
inhabitants, and by 2020, are very likely to 
be so in developing countries as well. (1) 
Distinguishing patients with ACS among 
those that present with suspected cardiac 
pain is a diagnostic challenge, especially 
in individuals without clear symptoms 
or electrocardiographic features. Despite 
modern treatment, mortality and readmis-
sion of patients with ACS remains high. 
(2) With diagnostic advances and treat-
ment of ACS, mortality in men has been 
reduced over the past decade; however, 
mortality in women has been increasing 
since 1984. (3) Previous studies have also 
shown that women and elderly with ACS 
are less likely to undergo diagnostic and 
therapeutic procedures than men. (4-10) 
Underestimation of risk by the treating 
physician and atypical presentation could 
be behind these findings, as well as the 
presumed increased risks of invasive treat-
ment in women. (11,12) The main reason 
why physicians choose conservative ther-
apy over percutaneous coronary interven-
tion (PCI) in the elderly is because they 
are concerned about the complications 
of an invasive approach in these patients. 
(13) Recent guidelines from the European 
Society of Cardiology suggest that age 
and sex should not be a criterion for con-
servative therapy because older people and 
women generally have better outcomes af-
ter prompt invasive treatments. (2) Recent 
studies also show benefits 1 and 5 years af-
ter PCI treatment in these patients. (14,15) 
Limited data, however, exist on in-hospital 
benefits of invasive therapy, especially in 
high risk groups. Because elderly female 
patients with ACS have the least chance of 
receiving invasive treatment, we wanted to 
determine whether there is a difference in 
hospital outcomes between conservative 
and invasive therapy in these patients.
MATERIAL AND METHODS
Study population
This retrospective, historical, controlled 
study included data from 123 postmeno-
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pausal women with a diagnosis of ACS 
admitted between February 1st and May 
1st, in 2007 or 2011, to the Coronary Care 
Unit (CCU) of the Clinic for heart and car-
diovascular diseases University Hospital of 
Split. Of the patients admitted during the 
study period in 2007, 70 were treated with 
conservative therapy and in 2011, 53 were 
treated with PCI. Cardiologists made a de-
cision about treatment with the patient’s 
approval. PCI and conservative treatment 
were administered according to European 
Society of Cardiology and other relevant 
guidelines at the time. (16,17)
The study was conducted according to 
the principles of the Declaration of Hel-
sinki. On 16th October, 2010 the Ethics 
Committee of University Hospital of Split 
approved the study under the protocol 
number 2181-147-01/06/J.B.-13-1. The 
chairperson of the ethics committee was 
Prof. Jugoslav Bagatin.
Data collection
Trained research assistants collected de-
mographic data (age, height and weight), 
socioeconomic status, date of admission, 
diagnosis on admission, symptoms on 
admission, physical examination findings 
on admission, duration of hospitalization, 
previously diagnosed illnesses, lifestyle 
habits, marital status, blood test results 
during hospitalization, clinical examina-
tion findings during hospitalization and 
drugs used before and during hospitaliza-
tion.
The participants were identified as either 
suffering from diabetes mellitus or not. Ar-
terial hypertension and year of diagnosis 
was categorized as previously diagnosed 
or previous use of antihypertensive drugs. 
The subjects were identified as either suf-
fering from arterial hypertension or not. 
In patients with a diagnosis of arterial hy-
pertension we also wrote the year when 
the arterial hypertension was diagnosed 
for the first time. Cigarette smoking was 
categorized as non-smokers or smokers, 
if they were smoking or had ever smoked. 
Dyslipidemia was diagnosed as an el-
evation of total cholesterol (>4.5mmol/L), 
low-density lipoprotein (LDL) cholesterol 
(>2.3 mmol/L) and triglyceride (TG) con-
centrations (>1.8mmol/L), and by a de-
crease in high-density lipoprotein (HDL) 
cholesterol concentration in the blood 
(<0.9 mmol/L). The subjects were identi-
fied as either having dyslipidemia or not. 
History of coronary artery bypass graft 
(CABG), ischemic heart disease, cerebro-
vascular insult, peripheral artery disease, 
myocardial infarction and PCI were char-
acterized as procedures or diagnoses that 
the participant had had until the present.
Heart failure was classified using the Kil-
lip classification (18) as Killip class 3 or 
4 and using the New York Heart Asso-
ciation functional classification (NYHA) 
(19) as NYHA class 3 or 4. Complications 
during hospitalization were described as 
complications that can occur after treat-
ment, modeled by recent guidelines. (2) 
Heart failure, death and arrhythmias, that 
can occur as complications of some treat-
ments, were observed separately. Arrhyth-
mia was classified as an abnormal heart 
rhythm: premature atrial and ventricular 
contractions, supraventricular tachycar-
dias, ventricular arrhythmias and bradyar-
rhythmias. Arrhythmia, ST elevation, ST 
depression, T waves and Q waves were di-
agnosed with the electrocardiograph mod-
el ECG-9620M (Nihon Kohden Corpora-
tion, Tokyo, Japan). Heart failure, LVEDD 
and LVEF were diagnosed with a Nemio 
SSA-550A ultrasound (Toshiba Corpora-
tion, Shimoishigami, Japan).
Laboratory Measurements
Morning blood was collected after 
12-hours of fasting and after a 20-minute 
morning rest. The following parameters 
were obtained: total cholesterol, LDL, 
HDL, TG and serum glucose by standard 
enzymatic methods on an Olympus AU-
640 (Olympus, Tokyo, Japan). LDL-C was 
calculated using Friedwald equation. If 
TG concentration was above 3 mmol/L, 
HDL-C and LDL-C were measured by di-
rect immunoinhibition method (Olympus 
Diagnostica, Lismeehan, Ireland) and ho-
mogeneous assay (Randox Laboratories, 
Crumlin, United Kingdom), respectively.
Statistical analysis
Data analysis was performed using the 
Statistica 10 software package (StatSoft 
Inc., Tulsa, OK, USA). Categorical vari-
ables were expressed as frequencies and 
percentages. A chi-square test was used to 
establish the relationship between pairs of 
categorical variables. Continuous variables 
were expressed as mean and standard devi-
ation (M±SD) whereas t-test for independ-
ent samples was used to check for statisti-
cal significance. The statistical significance 
level was set at 95% (p<0.05).
RESULTS
One hundred twenty three female patients 
participated in the study, with a mean age 
of 71 ± 8.7 of those treated conservative-
ly and 65 ± 8.8 of those treated with PCI 
(P<0.001, table 1). There was no signifi-
cant difference in their body mass index 
(BMI), systolic blood pressure or diastolic 
blood pressure, however among those 
treated with conservative therapy there 
was significantly less retirees than among 
those treated with PCI (n=9; 12.86% vs 
n=26; 52%, P<0.001). In the conservative 
group, the most common symptoms on 
admission were chest pain (n=41; 58.57% 
vs n=33; 62.26%, P<0.001) and dyspnea 
(n=28; 40% vs n=7; 13.21%, P<0.001). In 
the conservative group there were more 
patients who smoked (n=13; 25% vs n=7; 
10%, P=0.031) and who had dyslipidemia 
(n=33; 62% vs n=26; 37%, P=0.006, table 
1). Of the laboratory parameters, only tri-
glycerides were significantly higher in par-
ticipants treated with conservative therapy 
(2.21 ± 1.06) compared to those treated 
with PCI (1.66 ± 0.72, P=0.009, table 2). 
There were no statistical differences be-
tween heart failure (n=31; 44.28% vs n=28; 
52.83%, P=0.233, table 3) and death (n=2; 
2.86% vs n=1; 1.89%, P=0.73) during ad-
mission among the groups, however more 
arrhythmias were detected in the conserv-
ative group (n=29, 41.43% vs n=3, 5.66%, 
P<0.001) and less ST elevations (n=0; 0% 
vs n=9, 16.98%, P<0.001). Furthermore, 
during hospitalization there were signifi-
cantly more cases of heart failure among 
those treated with conservative therapy 
(n=20; 27.4%) compared to those treated 
with PCI (n=3; 5.66%, P=0.001, table 3). 
No differences were observed in complica-
tions that occurred during hospitalization 
between the groups.
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Table 1. Characteristics of study patients.
Conservative group (N=70) PCI group (N=53) P
Age (years; M ± SD)
BMI (kg/m²; M ± SD)
Systolic BP (mmHg, M ± SD)
Diastolic BP (mmHg, M ± SD)









































Duration of hospitalization (days; M ± SD) 6.46 ± 4.4 5.26 ± 3.61 0.111
Smoking n (%) 7 (10) 13 (24.53) 0.031*
Dyslipidemia n (%) 26 (37.14) 33 (62.26) 0.006*
Diabetes mellitus n (%) 14 (20) 12 (22.64) 0.722
Arterial hypertension n (%) 47 (67.14) 36 (69.92) 0.927
Year of arterial hypertension diagnosis (years; M ± SD) 43.45 ± 18.71 52.5 ± 8.36 0.087
History of CABG n (%) 0 (0) 1 (1.88) 0.249
History of ischemic heart disease n (%) 34 (48.57) 26 (49.06) 0.957
History of cerebrovascular insult n (%) 4 (5.71) 3 (5.66) 0.99
History of peripheral artery disease n (%) 0 (0) 1 (1.88) 0.249
History of myocardial infarction n (%) 13 (18.57) 11 (20.75) 0.762
History of PCI n (%) 6 (8.57) 11 (20.75) 0.053
BMI, body mass index; BP, blood pressure; CABG, coronary artery bypass graft; M±SD, arithmetic mean ± standard deviation; P, sig-
nificance level; *, P<0.05; PCI, percutaneous coronary intervention.
Table 2. Laboratory parameters on admission.
Conservative group (N=70) PCI group (N=53) P
Troponin (µg/L, M ± SD) 30.29 ± 72.22 3.2 ± 7.18 0.074
CKMB (U/L, M ± SD) 48.39 ± 99.46 60.54 ± 124.38 0.735
CK (U/L, M ± SD) 160.36 ± 406.17 356.64 ± 862.48 0.138
Hemoglobin (g/L, M ± SD) 129.31 ± 19.03 128.1 ± 11.55 0.694
Glucose (mmol/L, M ± SD) 7.44 ± 3.11 7.62 ± 4.19 0.791
Cholesterol (mmol/L, M ± SD) 4.43 ± 1.24 5.03 ± 1.37 0.165
Triglycerides (mmol/L, M ± SD) 2.21 ± 1.06 1.66 ± 0.72 0.009*
LDL (mmol/L, M ± SD) 3.48 ± 0.88 3.25 ± 1.06 0.281
HDL (mmol/L, M ± SD) 1.4 ± 0.49 1.33 ± 0.35 0.498
CK, creatinine kinase; CKMB, creatinine kinase myoglobin; HDL, high density lipoproteins; LDL, low density lipoproteins; M±SD, 
arithmetic mean ± standard deviation; P, significance level; *, P<0.05; PCI, percutaneous coronary intervention.
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Table 3. Treatment outcomes.
Conservative group (N=70) PCI group (N=53) P
Heart failure on admission N (%) 31 (44.28) 28 (52.83) 0.233
Death on admission N (%) 2 (2.86) 1 (1.89) 0.73
Arrhythmias during hospitaliza-
tion N (%)
29 (41.43) 3 (5.66) <0.001*
Heart failure during hospitalization 
N (%)
20 (27.4) 3 (5.66) <0.001*
Complications during hospitaliza-
tion N (%)
3 (4.29) 2 (3.77) 0.887
ST depression on ECG N (%) 8 (11.43) 5 (9.43) 0.722
ST elevation on ECG N (%) 0 (0) 9 (16.98) <0.001*
T wave on ECG N (%) 13 (18.57) 6 (11.32) 0.271
Q wave on ECG N (%) 2 (2.86) 3 (5.66) 0.436
LVEDD (mm, M ± SD) 53.48 ± 5.59 50.41 ± 7.77 0.275
LVEF (%, M ± SD) 48.32 ± 22.97 59.56 ± 16.56 0.185
ECG, electrocardiogram; LVEDD, left ventricular end-diastolic dimension; LVEF, left ventricular ejection fraction; M±SD, arithmetic 
mean ± standard deviation; P, significance level; *, P<0.05; PCI, percutaneous coronary intervention.
DISCUSSION
Women with ACS are more likely to be 
treated with conservative therapy than 
men. (4-10) Also, because of possible 
complication associated with the invasive 
approach, elderly are less often treated 
with PCI. (13) Although recent guide-
lines suggest that women and the elderly 
have better outcomes after prompt inva-
sive treatments, they are often treated with 
conservative therapy. (2) Because elderly 
female patients with ACS have the least 
chance of getting PCI, we wanted to deter-
mine whether there is a difference in hos-
pital outcomes between conservative and 
PCI in these patients.
In our study, chest pain was present in 
59% of patients on admission. This atypi-
cal presentation of patients with ACS has 
been well documented, especially in the 
elderly and women. (2) Although pa-
tients treated with PCI had more serious 
presenting symptoms and higher ST el-
evation during hospitalization, they had 
better treatment outcomes compared to 
patients treated with conservative therapy: 
including less infarctions and less arrhyth-
mias. There was no significant difference in 
complications during hospitalization after 
treatment when we compared these two 
groups, although there were slightly more 
complications compared to other studies. 
(20) The reason for this is most likely the 
higher age of our study groups.
Our study has several limitations. We col-
lected data on patients admitted to only 
one hospital in 2007 and 2011, and only for 
several months. The reason we chose 2011 
was because that was the first year we had 
complete data sets of PCI treated patients 
in those selected months. Another limita-
tion is that we did not analyze the drugs 
that patients were given during hospitali-
zation, only the type of treatment. Further 
studies should report on long term effects 
and include more patients when compar-
ing conservative and PCI in elderly wom-
en.
Conclusion of this retrospective study is 
that elderly female patients presenting with 
ACS and treated with PCI had significantly 
less arrhythmias and episodes of heart fail-
ure during hospitalization when compared 
to patients treated with conservative treat-
ment. These results suggest that even high 
risk patients have better outcomes after 
treatment with PCI, strengthening PCI as 
the suggested first-line treatment for ACS, 
regardless of associated risk factors.
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